Compounded Semaglutide and Tirzepatide Near You
Compounded GLP-1s are not FDA approved, and the rules around them have changed. The listings below are clinics whose websites mention semaglutide or tirzepatide. We do not know which of them compound, so ask each one.
Top cities for semaglutide and tirzepatide providers
Cities with the most clinic listings on GLPFinders whose websites mention semaglutide or tirzepatide. A listing does not mean a clinic offers a compounded product.
Five questions to ask before you start
- Is this product compounded or FDA approved, and what exactly is in the vial?
- Which pharmacy prepares it, and is it licensed in my state?
- Why does an FDA-approved drug not meet my medical needs?
- Who is the prescriber, and what is their license state?
- What is the full monthly cost, including supplies and any membership fee, in writing?
See also is compounded semaglutide legal, compounded vs brand tirzepatide, compounded vs brand-name GLP-1, semaglutide cost, semaglutide near me and tirzepatide near me.
Browse GLP-1 providers by state
1077 confirmed clinics in 50 states record this service; counts are clinics per state.
Frequently asked questions
Is compounded semaglutide or tirzepatide the same as Wegovy or Zepbound?
No. Wegovy and Zepbound are FDA-approved drugs. A compounded product is prepared by a pharmacy for an individual patient, and the FDA says compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed. A clinic that implies the two are equivalent is making a claim the FDA has objected to.
Is compounded semaglutide still legal?
The rules turned on the FDA shortage list. The FDA declared the tirzepatide shortage resolved and confirmed that on December 19, 2024, and declared the semaglutide shortage resolved in early 2025. Once a drug is off the list, compounders cannot regularly make copies of the approved product. The FDA says compounded drugs should be used only when an approved drug cannot meet a patient's medical needs, which is a decision for you and a licensed prescriber. We are not a source of legal advice.
Can the rules change again?
Yes. On April 30, 2026 the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the list of bulk substances that outsourcing facilities (503B) may use. The comment period closed on June 29, 2026. We have not found a final decision as of November 3, 2026, so check the FDA page for the current status.
Why do some clinics still advertise compounded GLP-1s?
Some clinics prescribe compounded versions when a prescriber documents an individual medical need, and others advertise more broadly than the FDA guidance supports. We cannot tell which is which from a clinic's website, so ask the questions above and get the answers in writing.
How do I check a compounding pharmacy?
Every state board of pharmacy has a public license lookup. Confirm the pharmacy is licensed in your state, that a real prescriber evaluates you before any medication is offered, and that you are told exactly what you will receive. Walk away from anyone selling these drugs without a prescription or shipping from overseas.
Is there a lower-cost approved option?
As reviewed November 3, 2026, Novo Nordisk lists Wegovy at $349 a month self-pay through NovoCare, with an introductory offer for eligible new patients through December 31, 2026. Lilly lists Zepbound self-pay vials through LillyDirect from $299 a month for 2.5 mg and $399 for 5 mg, with $449 for higher doses when refill terms are met. Program terms change, so confirm on each site.
Educational information, not medical advice. Listings are drawn from each clinic's own website and are not endorsements. Talk with a licensed provider before starting any medication.